-+ 0.00%
-+ 0.00%
-+ 0.00%

JASPER THERAPEUTICS - FIRST FSGS PATIENT IN PHASE 2 STUDY EXPECTED TO BE DOSED IN Q1 2027

路透·10/15/2026 12:00:04

請登錄查看新聞詳情